Eczema cream

A cream and eczema technology, applied in the field of pharmaceutical preparations for the treatment of skin diseases, can solve problems such as telangiectasia, pigmentation, complex prescriptions, etc., and achieve the effect of repairing damaged skin, anti-allergic damaged skin, and simple formula

Active Publication Date: 2016-11-09
NINGBO XINUOYA MARINE BIOTECH CO LTD
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, long-term use of hormones and antibiotics in clinical practice is prone to local adverse reactions such as drug resistance, skin atrophy, telangiectasia, and pigmentation.
[

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eczema cream

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] An eczema ointment, comprising the following raw materials in parts by weight:

[0038] Beta-glucan 25 parts

[0039] Purslane extract 2 parts

[0040] Panax notoginseng saponins 0.2 parts

[0041] 3 parts wheat germ oil

[0042] 3 parts grapeseed oil

[0043] 0.5 parts of cetearyl alcohol

[0044] 1 part cetearyl glucoside

[0045] Glyceryl monostearate 1 part

[0046] 30 parts of distilled water

Embodiment 2

[0048] An eczema ointment, comprising the following raw materials in parts by weight:

[0049] β-glucan 35 parts

[0050] Purslane extract 8 parts

[0051] Panax notoginseng saponins 1 part

[0052] Shea butter 5 parts

[0053] 2 parts wheat germ oil

[0054] 3 parts grapeseed oil

[0055] 8 parts olive oil

[0056]Perilla oil 0.5 parts

[0057] 2 parts cetearyl alcohol

[0058] 3 parts cetearyl glucoside

[0059] Glyceryl monostearate 1 part

[0060] 80 parts of distilled water

Embodiment 3

[0062] An eczema ointment, comprising the following raw materials in parts by weight:

[0063] β-glucan 28 parts

[0064] Purslane extract 3 parts

[0065] Panax notoginseng saponins 0.3 part

[0066] 2.5 parts wheat germ oil

[0067] Clove oil 0.5 parts

[0068] 4 parts olive oil

[0069] 0.6 parts of cetearyl alcohol

[0070] 1 part cetearyl glucoside

[0071] Glyceryl monostearate 1 part

[0072] 40 parts of distilled water

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an eczema cream. The eczema cream contains beta-glucosan component, and is used for treating skin diseases of eczema, dermatitis and the like. The eczema cream has the advantages that the functions of sterilizing, diminishing inflammation, maintaining moisture, fading pigment and the like are realized; the eczema cream is prepared from the raw materials from natural plants, and is applied to the fields of skin care products, health-care products, medical products and the like. The eczema cream is prepared from the following raw materials in parts by weight: 2 to 6 parts of emulsifier, 5 to 20 parts of natural plant oil, 25 to 35 parts of beta-glucosan, 2 to 10 parts of purslane extract liquid, 0.1 to 2 parts of panax notoginseng saponins, and 20 to 80 parts of pure water.

Description

technical field [0001] The invention relates to a pharmaceutical preparation for treating skin diseases, in particular to an eczema cream for treating eczema and dermatitis. Background technique [0002] Eczema is a common allergic skin disease, characterized by redness, edema, itching and dryness, which may be accompanied by scabbing, peeling, blistering, cracking, bleeding or oozing, with irregular course and repeated attacks. Intense itching. Recent studies have shown that eczema can be caused by a variety of microbial infections, and Staphylococcus aureus and Pityrosporum can be detected in eczema lesions. The key points in the treatment of eczema are sterilization, antipruritic, anti-inflammatory and moisturizing. Currently clinically mainly rely on glucocorticoid preparations, tar preparations, immunomodulators or antibiotic topical preparations to treat eczema. However, long-term use of hormones and antibiotics in clinical practice is prone to local adverse reactio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61K9/06A61K47/46A61P17/00A61P37/08A61P31/02A61P17/04A61K31/716
Inventor 贾艳诸辉
Owner NINGBO XINUOYA MARINE BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products